RESEARCH ARTICLE


Glucocorticoid-Induced Avascular Bone Necrosis: Diagnosis and Management



KL Chan, CC Mok*
Department of Medicine, Tuen Mun Hospital, Hong Kong, China


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 2387
Abstract HTML Views: 1026
PDF Downloads: 353
Total Views/Downloads: 3766
Unique Statistics:

Full-Text HTML Views: 1189
Abstract HTML Views: 592
PDF Downloads: 208
Total Views/Downloads: 1989



Creative Commons License
© Chan and Mok; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, SAR China; Tel: (852) 2468 5386; Fax: (852) 2456 9100; E-mail: ccmok2005@yahoo.com


Abstract

Glucocorticoid use is one of the most important causes of avascular bone necrosis (AVN). The pathogenesis of glucocorticoid-induced AVN is not fully understood but postulated mechanisms include fat hypertrophy, fat emboli and intravascular coagulation that cause impedance of blood supply to the bones. Data regarding the relationship between AVN and dosage, route of administration and treatment duration of glucocorticoids are conflicting, with some studies demonstrating the cumulative dose of glucocorticoid being the most important determining factor. Early recognition of this complication is essential as the prognosis is affected by the stage of the disease. Currently, there is no consensus on whether universal screening of asymptomatic AVN should be performed for long-term glucocorticoid users. A high index of suspicion should be exhibited for bone and joint pain at typical sites. Magnetic resonance imaging (MRI) or bone scintigraphy is more sensitive than plain radiograph for diagnosing early-stage AVN. Conservative management of AVN includes rest and reduction of weight bearing. Minimization of glucocorticoid dose or a complete withdrawal of the drug should be considered if the underlying conditions allow. The efficacy of bisphosphonates in reducing the rate of collapse of femoral head in AVN is controversial. Surgical therapy of AVN includes core decompression, osteotomy, bone grafting and joint replacement. Recent advances in the treatment of AVN include the use of tantalum rod and the development of more wear resistant bearing surface in hip arthroplasty.

Keywords: : Avascular, osteonecrosis, aseptic necrosis, corticosteroid, glucocorticoid.